Nerve sparing radical prostatectomy

State-of-the-art external beam radiotherapy

Seed Brachytherapy

Patient Information For High Dose Rate Hdr Prostate Brachytherapy

Hormonal therapy

 Prostatic cryotherapy

Systemic chemotherapy

Radioactive intravenous Strontium

Access to state-of-the-art clinical trial

Patient Information for Radiotherapy

  1. Pain relief for metastatic bone disease

  1. Clinical Trials

Radioactive intravenous Strontium

Strontium, like calcium, is a bone-seeking element when injected. A radio-isotope, Sr89, can be used to treat men when prostate cancer has spread to the bones. Sr89 is an effective way to kill bony metastases, thereby reducing bony pain, fractures and the need for external beam therapy. Side effects are negligible as long as the pre-treatment blood count is satisfactory. Sr89 can be repeated every 6 months, if required.